Ohio State Navbar

Ohio State Hematologist Regcognized Nationally

John Byrd has again received national scientific recognition for his translational research investigating use of the drug, ibrutinib, in the treatment of chronic lymphocytic leukemia, at the 2014 Clinical Research Forum’s third annual Top 10 Research Achievement Awards. Byrd is hematology division director and co-leader of the Leukemia Research Program at Ohio State’ Comprehensive Cancer Center – Arthur G. James Cancer Hospital & Richard J. Solove Research Institute (OSUCCC – James.) Read More